Literature DB >> 35505922

Using Telehealth for Diagnosis and Management of Non-Alcoholic Fatty Liver Disease.

Hamid-Reza Moein1, Elvis J Arteaga2, Souvik Sarkar2,3.   

Abstract

Content available: Author Interview and Author Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID: 35505922      PMCID: PMC9053681          DOI: 10.1002/cld.1191

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


  29 in total

1.  Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.

Authors:  Grishma Hirode; Eric Vittinghoff; Robert J Wong
Journal:  J Clin Gastroenterol       Date:  2019 Nov/Dec       Impact factor: 3.062

Review 2.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

Review 3.  Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care.

Authors:  Sanjeev Arora; Karla Thornton
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-07-21

Review 4.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

5.  The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.

Authors:  Marloes van Asten; Pauline Verhaegh; Ger Koek; Jef Verbeek
Journal:  Hepatology       Date:  2017-01-03       Impact factor: 17.425

6.  An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.

Authors:  Arianna Mazzotti; Maria Turchese Caletti; Lucia Brodosi; Silvia Di Domizio; Maria Luisa Forchielli; Salvatore Petta; Elisabetta Bugianesi; Giampaolo Bianchi; Giulio Marchesini
Journal:  J Hepatol       Date:  2018-10-02       Impact factor: 25.083

7.  Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.

Authors:  Nicole E Rich; Stefany Oji; Arjmand R Mufti; Jeffrey D Browning; Neehar D Parikh; Mobolaji Odewole; Helen Mayo; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-29       Impact factor: 11.382

8.  Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.

Authors:  Wenjie Dai; Ling Ye; Aizhong Liu; Shi Wu Wen; Jing Deng; Xin Wu; Zhiwei Lai
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

9.  Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Authors:  Marina Serper; Allen W Cubell; Mary Elisabeth Deleener; Tara K Casher; Dale J Rosenberg; Dale Whitebloom; Roy M Rosin
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

Review 10.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.